Department of Justice 2015 – Federal Register Recent Federal Regulation Documents

The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 79, Number 230, page 71127 on December 1, 2014, allowing for a 60 day comment period.

The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 79, Number 227, page 70203 on November 25, 2014, allowing for a 60 day comment period.

The Administrator of the Drug Enforcement Administration is issuing this final order to temporarily schedule three synthetic cannabinoids (SCs) into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA). The substances are: (1) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H- indazole-3-carboxamide (``AB-CHMINACA''); (2) N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (``AB-PINACA''); and (3) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanon e (``THJ-2201''). This action is based on a finding by the Administrator that the placement of these synthetic cannabinoids and their optical, positional, and geometric isomers, salts, and salts of isomers into schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, or possess), or propose to handle these SCs.

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

The National Coordination Committee on the American Indian/ Alaska Native (AI/AN) Sexual Assault Nurse Examiner (SANE)Sexual Assault Response Team (SART) Initiative (``National Coordination Committee'' or ``Committee'') will meet to carry out its mission to provide advice to assist the Office for Victims of Crime (OVC) to promote culturally relevant, victim-centered responses to sexual violence within AI/AN communities. Dates and Locations: The meeting will be held via webinar on Wednesday, February 18, 2015. The webinar is open to the public for participation. There will be a designated time for the public to speak, and the public can observe and submit comments in writing to Shannon May, the Designated Federal Official. Webinar space is limited. To register for the webinar, please provide your full contact information to Shannon May (contact information below).

Johnson Matthey, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Johnson Matthey, Inc. registration as a manufacturer of those controlled substances.

Cody Laboratories, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The DEA grants Cody Laboratories, Inc. registration as an importer of those controlled substances.

Euticals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Euticals, Inc. registration as a manufacturer of those controlled substances.

Lin Zhi International, Inc., applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Lin Zhi International, Inc. registration as a manufacturer of those controlled substances.

Noramco, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Noramco, Inc. registration as a manufacturer of those controlled substances.

Cerilliant Corporation applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Cerilliant Corporation registration as a manufacturer of those controlled substances.

AMPAC Fine Chemicals, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants AMPAC Fine Chemicals, LLC registration as a manufacturer of the controlled substances.

Chemtos, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Chemtos, LLC registration as a manufacturer of those controlled substances.

Boehringer Ingelheim Chemical, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Boehringer Ingelheim Chemical, Inc. registration as a manufacturer of the controlled substances.

The National Institute of Justice (NIJ) is soliciting information in relation to the upcoming National Criminal Justice Research, Test, and Evaluation Center (NIJ RT&E Center) ``Market Survey of Location-based Offender Tracking Technologies.'' This market survey will be published by NIJ to assist prospective agencies in their assessment of relevant information on commercially available offender tracking systems (OTS) marketed for use by the criminal justice community, prior to making purchasing decisions. The NIJ RT&E Center invites comments with regard to the market survey, including which categories of information are appropriate for comparison. Vendors of such technology are also invited to provide promotional material (e.g., slick sheet) and images of the technology (e.g., a print-quality photograph).

With the issuance of this final rule, the Administrator of the Drug Enforcement Administration removes naloxegol ((5[alpha],6[alpha])- 17-allyl-6-((20-hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl)oxy)- 4,5- epoxymorphinon-3,14-diol) and its salts from the schedules of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. Prior to the effective date of this rule, naloxegol was a schedule II controlled substance because it can be derived from opium alkaloids. This action removes the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle naloxegol.